ANGPT1 and COVID-19: In COVID-19, ACE2 showed opposite harmful effects as an entry point, and beneficial effect by counteracting the overstimulated RAS as it degrades AngII to angiotensin 1–7 (Ang1–7) (Kuster et al., 2020).